Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 288

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 288
---
 and product development strategy as it relates to the development and commercialization of a proprietary platform focused on prescription medication to over - the - counter switch solutions. The January 2025 Certificate of Amendment was filed with the Secretary of State of the State of Delaware, effective as of January 24, 2025. On February 10, 2025, the Company amended the Plan (the “Plan Amendment”) to remove certain individual limitations on the number of stock options, stock appreciation rights, shares of restricted stock and restricted stock units that could be awarded to an employee participant in any fiscal year pursuant to Section 4(d) of the Plan. On February 13, 2025, the Company filed a Certificate of Designations with the Secretary of State of the State of Delaware, establishing the designations, preferences, powers and rights of the shares of a new series of the Company’s preferred stock, Series B Convertible Preferred Stock, and was effective immediately on filing.

<div align='center'>F-55</div>

#### Up to 74,349,442 Units, Each Unit Consisting of One Share of Common Stock or OnePre-Funded Warrants to Purchase One Share of Common Stock, One Series A Warrant to Purchase 0.001 Share of Series B Convertible Preferred Stock and One Series B Warrant to Purchase 0.001 Share of Series B Convertible Preferred Stock​Up to 74,349,442 Shares of Common Stock Underlying the Pre-Funded Warrants and Up to 297,397.768 Shares of Series B Preferred Stock Underlying Series A Warrants and Series B WarrantsPROSPECTUSDawson James Securities, Inc., 2025​​
#### ​

PART II INFORMATION NOT REQUIRED IN PROSPECTUS

| Item 13. | Other Expenses of Issuance and Distribution |

The following table sets forth the fees and expenses, other than placement agent fees and expenses, payable in connection with the registration of the securities hereunder. All amounts are estimates except the SEC registration fee and the FINRA filing fee.

| Item                             | ​ | Amount     
 to be paid |         | ​ |
|:---------------------------------|:--|:-----------|--------:|:--|
| SEC registration fee             | ​ | $          |  15,310 | ​ |
| FINRA filing fee                 | ​ | $          |   7,250 | ​ |
| Printing expenses                | ​ | $          |  10,000 | ​ |
| Legal fees